POTENTIAL MEDICAL APPLICATIONS OF TRANSCRANIAL DOPPLER VELOCITIES IN CHILDREN WITH SICKLE CELL DISEASE by Shuford, Kendra
 POTENTIAL MEDICAL APPLICATIONS OF TRANSCRANIAL DOPPLER VELOCITIES IN CHILDREN WITH SICKLE 
CELL DISEASE 
by 
Kendra Shuford 
 
A Senior Honors Project Presented to the  
Honors College 
East Carolina University 
In Partial Fulfillment of the 
Requirements for  
Graduation with Honors 
by 
Kendra Shuford 
Greenville, NC 
May 2017 
 
 
 
 
 
Approved by: 
Dr. Beng Fuh 
Brody School of Medicine- Department of Pediatric Hematology/Oncology 
 
 
Abstract 
Although it is a topic of importance, research is scarce concerning renal dysfunction in pediatric 
sickle cell patients. Elevated blood pressure, increased urinary protein, and other signs and symptoms of 
early chronic kidney disease (CKD) are commonly found in children with sickle cell disease (SCD); the 
purpose of this study was to investigate a potential method for detecting renal dysfunction and the signs 
of CKD in children before the problem escalates. Transcranial Doppler (TCD) is a method used in sickle 
cell patients to determine their risk of stroke. It has to be presumed that in addition to CNS 
vasculopathy, SCD cause vasculopathy in other organs. It is not clear if there is a relationship between 
TCD velocity and renal damage. The purpose of this study was to investigate the relationship between 
TCD values and renal function. After obtaining appropriate institutional review board (IRB) approval, a 
retrospective chart review of 90 pediatric sickle cell patients managed at Vidant Medical Center, in 
Greenville in North Carolina was performed, to test the use of TCD in detecting dysfunction in the renal 
system. Statistical analysis was then completed to evaluate the relationship between these variables. 
The renal values collected were serum creatinine (SCR) and urine creatinine (UCR), blood urea nitrogen 
BUN, and Albumin/Creatinine Ratio (ACR); these renal values were individually analyzed. The TCD values 
collected consisted of the maximum velocities of the right middle cerebral artery (rMCA),  left middle 
cerebral artery (lMCA), right internal carotid artery (rICA), and left internal carotid artery (l ICA). Based 
on their TCD values, patients were categorized as normal, conditionally abnormal, or abnormal. There 
was a statistically significant difference in the SCR values across the three subject groups, however, this 
finding may be questioned when age is factored into this variable. The results indicate that BUN, UCR, 
and ACR cannot be used to determine if TCD velocities are a useful tool in the early detection of renal 
dysfunction in patients with sickle cell disease. However, lower SCR values were seen in patients with 
higher TCD velocities, therefore the use of TCD values to detect renal dysfunction should not be ruled 
out based on this study. 
 
Introduction 
Prevalence of Sickle Cell Disease 
 Sickle cell disease is a recessive condition affecting about 100.000 individuals in the United 
States and millions worldwide. According to a survey conducted by the Centers for Disease Control and 
Prevention (CDC) and the National Institutes for Health (NIH)’s, National Heart, Lung, and Blood Institute 
(NHLBI) in 2008, Sickle Cell Disease (SCD) occurs in approximately 1 out of every 1,435 births in North 
Carolina. From 2004-2008. Approximately 5,578 residents of North Carolina were reported to have SCD. 
Out of those 5,578 residents around 2,175 were under the age of eighteen.1  
Sickle Cell Disease Pathophysiology 
Sickle Cell Disease is caused by a mutation in the beta-globin gene. The 17th nucleotide is altered 
from thymine to adenine. The sixth amino acid of that beta-globin then becomes valine, a hydrophobic 
amino acid, instead of hydrophilic glutamic acid. This creates what is called a “S” mutation.2 When this 
mutant hemoglobin is deoxygenated it becomes extremely insoluble and rigid causing damage to the 
membrane of the red blood cells (RBCs) and adhesion of the RBCs to the endothelium of the blood 
vessel wall [Figure 1]. This RBC damage and adhesion can cause repeated vascular occlusion, anemia, 
acute chest syndrome (ACS), stroke, pain crisis, and eventually organ damage, including renal damage.3  
 
 
  
Figure 1 Virtual representation of a blood vessel containing  
normal red blood cells and a blood vessel containing sickled,  
red blood cells.11 From this figure, the vasoocclusion occurring due to sickled red 
blood cell can be seen. 
Renal Dysfunction 
The organs that are most commonly affected by SCD are the spleen, lungs, kidneys, liver, and 
brain.3 Mutant hemoglobins are likely to polymerize in the renal medulla because that area has a low 
partial pressure of oxygen, low pH, and osmolality is high causing dehydration of the RBCs.4 
The four renal values that were extracted for analysis were SCR, BUN, UCR, and ACR. Serum 
creatinine, or SCR, tends to be significantly lower in children with SCD because children with SCD have a 
high glomerular filtration rate (GFR) and exhibit hypersecretion of creatinine. In addition, these patients 
tend to have a lower muscle mass. The interpretation of serum creatinine must take this into account. 
Values near the low end of the normal range should increase suspicion for impaired renal function.5 
Elevated blood urea nitrogen (BUN) levels are associated with an increased risk of death in children.6 
Urine creatinine (UCR) measures the amount of creatinine excretion. Lastly, urine albumin: creatinine 
ratio (ACR), when combined with GFR can support the early detection of renal dysfunction.7 
30% of adults with SCD develop chronic renal failure; it is a common cause-of-death in the sickle 
cell population.8 The early symptoms for this disease (hyperfiltration, elevated blood pressure, 
proteinuria, etc.) are often seen in children.9 If no precautionary measures are taken to reduce the 
demand placed on the kidneys of that child, these initial complications can develop into full CKD in 
adulthood. Currently, there is no validated tools to screen for early kidney dysfunction in pediatric sickle 
cell patients and research in this area is severely deficient. Therefore, it is essential to develop a method 
to detect kidney damage early in patients with SCD.3 Given the pathophysiology behind sickle cell 
disease and the effect it has on circulation, it is worth investigating whether a correlation can be found 
between transcranial and renal blood flow and if this is related to renal dysfunction in patients with SCD. 
Abnormal renal blood flow may cause renal damage or dysfunction that may be evident in the patient’s 
laboratory values pertaining to their renal function. 
 
Transcranial Doppler Ultrasonography 
 Transcranial Doppler (TCD) ultrasonography is used to successfully detect intracranial artery 
stenosis, or narrowing of the blood vessels, in patients with SCD.10 Research has shown that an increase 
in TCD velocity in the cerebral arteries is correlated with an increase in stroke risk. Therefore, the 
purpose of this study was to assess the relationship between TCD velocities and values used to assess 
renal function (SCR, BUN, UCR, and ACR). TCD is safe and acceptable for use on children with a relatively 
low cost.10 TCD velocities for the right and left middle cerebral artery (rMCA and lMCA) and the right and 
left internal carotid artery (rICA and l ICA) were extracted because the majority of the patients had 
values for these four arteries. Recommendations for TCD velocities differ slightly depending on the 
source, however, Adams et al. were able to establish a threshold for abnormal blood flow velocity in 
SCD patients that can be generally agreed upon.10 The established level is forty to fifty percent higher 
than the average velocity for SCD patients without anemia.10 The threshold established for abnormal 
blood flow velocity is greater than or equal to 170 centimeters per second (cm/s).10 From this threshold, 
three classification groups were defined for the subjects based on their TCD values. If all four values 
were less than 130 cm/s, the subject was classified as normal. If one or more of the four values were 
within the range of 130-169 cm/s and none of the values were greater than 170 cm/s, the subject was 
classified as conditionally abnormal. Lastly, if one or more of the values was greater than or equal to 170 
cm/s, the subject was classified as abnormal.   
It is reasonable to hypothesize that abnormal transcranial blood flow may indicate abnormal 
renal blood flow because the organ systems are interrelated and rely heavily on the body’s blood 
composition and the blood vessels’ vasculature. The purpose of this study was to establish whether 
there is a correlation between abnormal transcranial blood flow velocity, abnormal renal laboratory 
values, and evidence of renal dysfunction in patients with sickle cell disease. 
 
Methods 
Ethical Considerations 
 All of the data in this study contained no patient identifiers and was collected using a 
retrospective chart review. A separate code sheet was kept as an index of which patients were used in 
this study. Therefore, it was not necessary to obtain consent from the patient prior to assessing the 
relevant patient charts. Prior to any data collection, approval for the study was obtained from East 
Carolina University’s Institutional Review Board. All data pertaining to this study and the code sheet 
were stored on the Department of Hematology/Oncology’s Pirate Drive throughout the course of this 
study.  
 
Patient Population and Data Extraction 
A retrospective chart review was completed using a pool of patients seen by the doctors in the 
Pediatric Hematology/Oncology Department at Vidant Medical Center in Greenville, NC. Ninety total 
patients, 2-16 years old, were selected for the study based on whether they had the majority of the 
necessary data values. Forty-seven out of ninety patients in the study were female and forty-three were 
male. In order to be included in the study, the subject must have had all four TCD velocities in order to 
be included. Thirty patients with normal TCD velocities, thirty patients with conditionally abnormal TCD 
velocities, and thirty patients with abnormal TCD velocities were selected. In the data file, subjects were 
coded with a number. A separate code sheet was created for each subject’s name, date of birth, and 
their subject number. Once the data was extracted for all ninety subjects, the full dataset was analyzed 
for any errors during extraction. 
 
Statistical Analysis 
 Statistical analysis was completed using IBM SPSS software. The subjects were categorized by 
TCD condition as abnormal, conditionally abnormal, and abnormal. ACR values were also categorized as 
normal, moderately increased, and severely increased. Twelve scatter plots were generated. Four 
scatter plots each were generated to compare each of the renal values (SCR, BUN, and UCR) to the 
individual TCD velocities extracted: rMCA, rICA, l MCA, and l ICA. Three side-by-side boxplots were 
generated depicting the SCR, BUN, and UCR values within the three TCD conditions. The side-by-side 
boxplot of SCR vs. TCD condition can be seen in Figure 2. Four scatter plots were generated depicting 
ACR condition (no data, normal, moderately increased, or severely increased) versus the individual TCD 
velocities: rMCA, rICA, l MCA, and l ICA. A One-way ANOVA was then used to determine if there was a 
significant difference in the renal values from one TCD group to another, the results are in Table 1. 
 
Figure 2 Serum Creatinine values sorted by TCD condition. From this figure, it can be 
observed that as TCD velocity increased, serum creatinine decreases. 
 
ANOVA 
 df p-value 
Serum Creatinine (SCR) 2 0.041 
Blood Urea Nitrogen (BUN) 2 0.118 
Urine Creatinine (UCR) 2 0.440 
Table 1 Anova results of SCR, BUN, and UCR comparative analysis. From the p-value, significant 
difference can be seen in the SCR values across the three TCD conditions. 
 
 
Results 
Participants 
 Only patients with sickle cell disease and documented TCD velocities in all necessary vessels as 
well and renal function studies were included. However, no patients with systemic disease were 
included in the study due to the fact that this could cause a change in their renal values. Only patients 
with diagnosed SCD who are 2-16 years old were included since this is the age group routine screened 
using TCD. Forty-seven out of ninety patients in the study were female and forty-three were male. There 
was not a very large pool of patient who has all of the qualifying information that were not included in 
the study. 
 
Statistical Results 
 The results of the study indicate that there is no significant difference in the BUN and UCR 
values across the three TCD conditions, with p-values of 0.118 and 0.440 respectively, and no trends can 
be seen in the graphs generated to assess the changes in ACR. However, there was a significant 
difference in the SCR values across the three TCD conditions (p-value=0.41). Subjects with higher TCD 
velocities, particularly high rMCA velocities, tended to have lower SCR values. As a reminder, those with 
renal dysfunction, typically have lower SCR values. There are three outliers to this trend. One subject in 
the normal TCD condition and two subjects in the abnormal TCD condition were found to have SCR 
values above their group counterparts. 
 
Conclusion 
 The results indicate that BUN, UCR, and ACR should not be used to test if TCD velocities can be 
used as a tool in the early detection of renal dysfunction in patients with sickle cell disease. However, 
lower SCR values were seen in patients with higher TCD velocities, with a few exceptions, which suggests 
that TCD velocities should not be completely ruled out based on this study. One of the limitations of this 
study was the small pool of patients included in this study, however, this was the first stage of a larger 
study and it was an appropriate as a starting point. In order to determine further if TCD velocities can be 
used as a tool in the early detection of renal dysfunction in patients with SCD, other renal values that are 
better known to be better predictors of renal dysfunction, such as cystatin-C and N-acetyl-B-D-
glucosaminidase, should be collected as well. This may be difficult since these values are not routine 
checked during comprehensive sickle cell management visits and must be specifically collected in order 
to be analyzed.  
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